cAMP-adenosine pathway in the proximal tubule

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 3, 2006, Pages 1219-1229

  Jackson, Edwin K ^a   Zacharia, Lefteris C ^a   Zhang, Mingdi ^a   Gillespie, Delbert G ^a   Zhu, Chongxue ^a   Dubey, Raghvendra K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENYLATE CYCLASE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; CYCLIC AMP; ECTO 5' NUCLEOTIDASE; ECTOPHOSPHODIESTERASE INHIBITOR; INOSINE; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG INHIBITION; IN VIVO STUDY; ION TRAP MASS SPECTROMETRY; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CELLS, CULTURED; CULTURE MEDIA; CYCLIC AMP; EPITHELIAL CELLS; KIDNEY TUBULES, PROXIMAL; MALE; MICRODIALYSIS; RATS; RECEPTORS, PURINERGIC P1;

EID: 33646782273     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.101360     Document Type: Article

References (40)

1. 2-receptor antagonists on intrarenal blood flow. Am J Physiol 265:F802-F806.
2. Barber R and Butcher RW (1981) The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells. Mol Pharmacol 19:38-43.
3. Beavo JA and Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155.
4. Biber J, Stieger B, Haase W, and Murer H (1981) A high yield preparation for rat kidney brush border membranes. Different behaviour of lysosomal markers. Biochim Biophys Acta 647:169-176.
5. 1 receptor-deficient mice. Am J Physiol 281:R1362-R1367.
6. 1 receptor antagonist, on sodium-dependent phosphate and glucose transport by the rat renal proximal tubular cell. Life Sci 55:839-845.
7. 1 receptor antagonist, is mediated by cyclic adenosine monophosphate. Am J Kidney Dis 26:825-830.
8. Coulson R, Johnson RA, Olsson RA, Cooper DR, and Scheinman SJ (1991) Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells. Am J Physiol 260:F921-F928.
9. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (1997) Cyclic AMP-adenosine pathway inhibits glomerular mesangial cell growth (Abstract). Hypertension 30:506.
10. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2000) Cardiac fibroblasts express the cAMP-adenosine pathway. Hypertension 36:337-342.
11. Dubey RK, Mi Z, Gillespie DG, and Jackson EK (1996) Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension 28:765-771.
12. Hansen PB and Schnermann J (2003) Vasoconstrictor and vasodilator effects of adenosine in the kidney. Am J Physiol 285:F590-F599.
13. Hanson AS and Linas SL (1995) Beta-adrenergic receptor function in rat proximal tubule epithelial cells in culture. Am J Physiol 268:F553-F560.
14. Hedqvist P and Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn-Schmiedeberg's Arch Pharmacol 293:217-223.
15. Hedqvist P, Fredholm BB, and Olundh S (1978) Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 43:592-598.
16. Holz FG and Steinhausen M (1987) Renovascular effects of adenosine receptor agonists. Renal Physiol 10:272-282.
17. Jackson EK (1991) Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol 31:1-35.
18. Jackson EK (1997) Renal actions of purines, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 217-250, Wiley-Liss, New York.
19. Jackson EK (2001) P1 and P2 receptors in the renal system, in Handbook of Experimental Pharmacology Volume 151/II; Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio MP and Williams M eds) pp 33-71, Springer-Verlag, Berlin.
20. Jackson EK and Dubey RK (2001) Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol 281:F597-F612.
21. Jackson EK and Mi Z (2000) Preglomerular microcirculation expresses the cAMP-adenosine pathway. J Pharmacol Exp Ther 295:23-28.
22. Jackson EK, Mi Z, Gillespie DG, and Dubey RK (1997) Metabolism of cAMP to adenosine in the renal vasculature. J Pharmacol Exp Ther 283:177-182.
23. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, and Herzer WA (1996) Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther 279:1250-1260.
24. Jackson EK, Mi Z, Zhu C, and Dubey RK (2003) Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307:888-896.
25. Jackson EK, Zhu C, and Tofovic SP (2002) Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol 283:F41-F51.
26. Joyner WL, Mohama RE, Myers TO, and Gilmore JP (1988) The selective response to adenosine of renal microvessels from hamster explants. Microvasc Res 35:122-131.
27. Kim SM, Mizel D, Huang YG, Briggs JP, and Schnermann J (2005) Adenosine as a mediator of macula densa-dependent inhibition of renin secretion. Am J Physiol DOI: 10.1152/ajprenal.00367.
28. Kinsella JL, Holohan PD, Pessah NI, and Ross CR (1979) Isolation of luminal and antiluminal membranes from dog kidney cortex. Biochim Biophys Acta 552:468-477.
29. Kuster J, Zapf J, and Jakob A (1973) Effects of hormones on cyclic AMP release in perfused rat livers. FEBS Lett 32:73-77.
30. Mi Z and Jackson EK (1995) Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther 273:728-733.
31. 2A receptors on renal microvascular reactivity. Am J Physiol 280:F406-F414.
32. 1 adenosine receptors. Hypertension 46:780-786.
33. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, and Endou H (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526-18529.
34. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, and Schnermann J (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98:9983-9988.
35. Takahashi T, Kakuno K, Yamada H, and Endou H (1989) Intranephron distribution of purine-metabolizing enzymes in rats. Renal Physiol Biochem 12:287-294.
36. 1 receptor. Am J Physiol 265:F511-F519.
37. Tofovic SP, Branch KR, Oliver RD, Magee WD, and Jackson EK (1991) Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
38. van Aubel RA, Smeets PH, Peters JG, Bindels RJ, and Russel FG (2002) The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 13:595-603.
39. Vekaria RM, Shirley DG, Sevigny J, and Unwin RJ (2006) Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol 290:F550-F560.
40. Zimmermann H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285 (Pt 2):345-365.